Physician

Steven Gary Safran, M.D.

According to 2025 Medicare claims, Steven Safran, M.D. (NPI: 1386624864) practices ophthalmology in the Trenton-Princeton, NJ market, with the plurality of this provider's patient population coming from Mercer, NJ. This provider's primary affiliated billing organization is STEVEN G SAFRAN MD,PA (NPI: 1639210040; TIN: 223282121) and primary practice location at 08648-2523.

Safran's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 913 traditional Medicare patients, billed 2,482 HCPCS/CPT codes, and received $352,989 in Medicare payments. The top billing code was 92004 (New patient complete exam of visual system). Part D data shows 2,330 prescription claims across 522 beneficiaries totaling $314,962 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 16 records totaling $831. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have changed little. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$274K$548K2015 Medicare payment: $547,506 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $450,426 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $395,532 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $412,874 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $339,592 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $278,241 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $348,688 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $376,937 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $418,389 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $352,989 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,1374,732$547,506
20161,0403,441$450,426
20179392,875$395,532
20189372,700$412,874
20197892,250$339,592
20207342,016$278,241
20218412,388$348,688
20229042,419$376,937
20239602,619$418,389
20249132,482$352,989

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$197K$394K2015 Drug cost: $394,460 (USD; Tot_Drug_Cst)2016 Drug cost: $322,441 (USD; Tot_Drug_Cst)2017 Drug cost: $340,014 (USD; Tot_Drug_Cst)2018 Drug cost: $348,955 (USD; Tot_Drug_Cst)2019 Drug cost: $346,077 (USD; Tot_Drug_Cst)2020 Drug cost: $338,197 (USD; Tot_Drug_Cst)2021 Drug cost: $339,393 (USD; Tot_Drug_Cst)2022 Drug cost: $333,106 (USD; Tot_Drug_Cst)2023 Drug cost: $316,994 (USD; Tot_Drug_Cst)2024 Drug cost: $314,962 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20156132,572$394,460
20164952,012$322,441
20174881,985$340,014
20184861,905$348,955
20194932,006$346,077
20204541,797$338,197
20214761,985$339,393
20224511,952$333,106
20234902,269$316,994
20245222,330$314,962

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92004New patient complete exam of visual system232232$115
92014Established patient complete exam of visual system428444$94
92012Established patient problem focused exam of visual system251315$67
92134Imaging of retina191193$31
92136Measurement of corneal curvature and depth of eye211225$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine833,915$79,855
LumiganBimatoprost763,143$28,740
CyclosporineCyclosporine442,670$28,245
XiidraLifitegrast26900$20,694
ProlensaBromfenac Sodium451,571$16,789

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.16$831Johnson & Johnson Surgical Vision, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Steven Gary Safran, M.D.?

Tedicare shows public-source Medicare data for Steven Gary Safran, M.D. (NPI 1386624864), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Steven Gary Safran, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Steven Gary Safran, M.D.?

Steven Gary Safran, M.D. is linked to STEVEN G SAFRAN MD,PA (billing NPI 1639210040) in the available physician profile data.

Does Steven Gary Safran, M.D. have Open Payments data?

Steven Gary Safran, M.D. has 16 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.